Physician

Kimberly Tamargo, MD

According to 2025 Medicare claims, Kimberly Tamargo, MD (NPI: 1003336140) practices dermatology in the Akron, OH market, with the plurality of this provider's patient population coming from Summit, OH. This provider's primary affiliated billing organization is ALLIED DERMATOLOGY AND SKIN SURGERY, LLC (NPI: 1932592698; TIN: 473030711) and primary practice location at 44333-4510.

Tamargo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 574 traditional Medicare patients, billed 3,475 HCPCS/CPT codes, and received $161,656 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,360 prescription claims across 629 beneficiaries totaling $314,730 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 126 records totaling $2,482. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $285 to $314,730. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$83K$167K2021 Medicare payment: $53,836 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $166,636 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $164,380 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $161,656 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021237921$53,836
20225573,248$166,636
20235693,318$164,380
20245743,475$161,656

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$231K$462K2017 Drug cost: $285 (USD; Tot_Drug_Cst)2018 Drug cost: $20,352 (USD; Tot_Drug_Cst)2019 Drug cost: $228,910 (USD; Tot_Drug_Cst)2020 Drug cost: $133,659 (USD; Tot_Drug_Cst)2021 Drug cost: $93,606 (USD; Tot_Drug_Cst)2022 Drug cost: $209,692 (USD; Tot_Drug_Cst)2023 Drug cost: $462,294 (USD; Tot_Drug_Cst)2024 Drug cost: $314,730 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R17$285
201867148$20,352
2019156489$228,910
2020125385$133,659
2021228451$93,606
20224691,011$209,692
20236031,310$462,294
20246291,360$314,730

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths157192$71
11102Biopsy of related skin growth, first growth309420$57
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more382560$54
17000Destruction of precancer skin growth, 1 growth303441$32
17003Destruction of precancer skin growth, 2-14 growths192930$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab21784$109,371
OtezlaApremilast12360$60,601
FluorouracilFluorouracil672,031$4,435
KetoconazoleKetoconazole2648,659$4,300
DesonideDesonide641,767$2,630

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.126$2,482ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kimberly Tamargo, MD?

Tedicare shows public-source Medicare data for Kimberly Tamargo, MD (NPI 1003336140), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kimberly Tamargo, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kimberly Tamargo, MD?

Kimberly Tamargo, MD is linked to ALLIED DERMATOLOGY AND SKIN SURGERY, LLC (billing NPI 1932592698) in the available physician profile data.

Does Kimberly Tamargo, MD have Open Payments data?

Kimberly Tamargo, MD has 126 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.